Venlafaxine (Venish (75 mg)) is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI), prescribed for depression, generalized anxiety disorder, social anxiety disorder, and panic ...

Nov. 28, 2005 -- The U.S. Food and Drug Administration (FDA) has approved extended-release venlafaxine HCl capsules for the treatment of adults with panic disorder; sodium oxybate oral solution for ...

Low-dose estradiol and low-dose venlafaxine were both effective and well-tolerated in a trial comparing them with placebo as treatments for vasomotor symptoms (VMS) in peri- and postmenopausal women, ...

Several studies have suggested that antidepressants might be beneficial in the treatment of patients with functional gastrointestinal disorders. This commentary discusses the results of a high-quality ...

As with all medications, the cost of venlafaxine can vary. Factors that may affect the price you’ll pay include your treatment plan, your insurance coverage, and the pharmacy you use. To find out what ...

Wyeth New Zealand, provider of the antidepressant medicine Efexor®-XR (venlafaxine extended release), is pleased to announce that agreement has been reached with the New Zealand Government's funding ...